Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Baseline Colonoscopy Findings Associated with 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.

Lieberman D, Sullivan BA, Hauser ER, Qin X, Musselwhite LW, O'Leary MC, Redding TS 4th, Madison AN, Bullard AJ, Thomas R, Sims KJ, Williams CD, Hyslop T, Weiss D, Gupta S, Gellad ZF, Robertson DJ, Provenzale D.

Gastroenterology. 2019 Jul 31. pii: S0016-5085(19)41149-9. doi: 10.1053/j.gastro.2019.07.052. [Epub ahead of print]

PMID:
31376388
2.

Financial Costs and Burden Related to Decisions for Breast Cancer Surgery.

Greenup RA, Rushing C, Fish L, Campbell BM, Tolnitch L, Hyslop T, Peppercorn J, Wheeler SB, Zafar SY, Myers ER, Hwang ES.

J Oncol Pract. 2019 Aug;15(8):e666-e676. doi: 10.1200/JOP.18.00796. Epub 2019 Jul 29.

PMID:
31356147
3.

Decreasing rates of axillary lymph node dissections over time: Implications for surgical resident exposure and operative skills development.

Rosenberger LH, Thomas SM, Plichta JK, Fayanju OM, Hyslop T, Greenup RA, Hwang ES.

Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30110-2. doi: 10.1016/j.amjsurg.2019.07.013. [Epub ahead of print]

PMID:
31350006
4.

Clinical and pathological stage discordance among 433,514 breast cancer patients.

Plichta JK, Thomas SM, Sergesketter AR, Greenup RA, Fayanju OM, Rosenberger LH, Tamirisa N, Hyslop T, Hwang ES.

Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30099-6. doi: 10.1016/j.amjsurg.2019.07.016. [Epub ahead of print]

PMID:
31350005
5.

Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.

Thornton MJ, Williamson HV, Westbrook KE, Greenup RA, Plichta JK, Rosenberger LH, Gupta AM, Hyslop T, Hwang ES, Fayanju OM.

Ann Surg Oncol. 2019 Oct;26(10):3166-3177. doi: 10.1245/s10434-019-07564-9. Epub 2019 Jul 24.

PMID:
31342392
6.

Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons.

Greenup RA, Rushing CN, Fish LJ, Lane WO, Peppercorn JM, Bellavance E, Tolnitch L, Hyslop T, Myers ER, Zafar SY, Hwang ES.

Ann Surg Oncol. 2019 Oct;26(10):3141-3151. doi: 10.1245/s10434-019-07594-3. Epub 2019 Jul 24.

PMID:
31342390
7.

Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.

Zambeli-Ljepović A, Wang F, Dinan MA, Hyslop T, Stang MT, Roman SA, Sosa JA, Scheri RP.

Surgery. 2019 Jul 6. pii: S0039-6060(19)30308-3. doi: 10.1016/j.surg.2019.05.035. [Epub ahead of print]

PMID:
31288935
8.

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.

Martín M, Loibl S, Hyslop T, De la Haba-Rodríguez J, Aktas B, Cirrincione CT, Mehta K, Barry WT, Morales S, Carey LA, Garcia-Saenz JA, Partridge A, Martinez-Jañez N, Hahn O, Winer E, Guerrero-Zotano A, Hudis C, Casas M, Rodriguez-Martin C, Furlanetto J, Carrasco E, Dickler MN; GEICAM Spanish Breast Cancer Group; GBG (German Breast Group); Alliance for Clinical Trials in Oncology (Alliance).

Eur J Cancer. 2019 Aug;117:91-98. doi: 10.1016/j.ejca.2019.06.002. Epub 2019 Jul 2.

9.

Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.

Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1316-1323. doi: 10.1158/1055-9965.EPI-18-1262. Epub 2019 Jun 11.

PMID:
31186262
10.

Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.

Zambeli-Ljepović A, Wang F, Dinan MA, Hyslop T, Roman SA, Sosa JA, Scheri RP.

J Surg Res. 2019 Jun 8;243:189-197. doi: 10.1016/j.jss.2019.05.029. [Epub ahead of print]

PMID:
31185435
11.

Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.

Grimm LJ, Miller MM, Thomas SM, Liu Y, Lo JY, Hwang ES, Hyslop T, Ryser MD.

Radiology. 2019 Jul;292(1):77-83. doi: 10.1148/radiol.2019182599. Epub 2019 May 21.

PMID:
31112087
12.

The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.

Tamirisa N, Williamson HV, Thomas SM, Westbrook KE, Greenup RA, Plichta JK, Rosenberger LH, Hyslop T, Hwang ES, Fayanju OM.

J Surg Oncol. 2019 Aug;120(2):132-141. doi: 10.1002/jso.25492. Epub 2019 May 6.

PMID:
31062375
13.

The Influence of Age on the Histopathology and Prognosis of Atypical Breast Lesions.

Sergesketter AR, Thomas SM, Fayanju OM, Menendez CS, Rosenberger LH, Greenup RA, Hyslop T, Parrilla Castellar ER, Hwang ES, Plichta JK.

J Surg Res. 2019 Sep;241:188-198. doi: 10.1016/j.jss.2019.03.047. Epub 2019 Apr 24.

PMID:
31028940
14.

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.

Snook AE, Baybutt TR, Xiang B, Abraham TS, Flickinger JC Jr, Hyslop T, Zhan T, Kraft WK, Sato T, Waldman SA.

J Immunother Cancer. 2019 Apr 23;7(1):104. doi: 10.1186/s40425-019-0576-2.

15.

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).

Hwang ES, Hyslop T, Lynch T, Frank E, Pinto D, Basila D, Collyar D, Bennett A, Kaplan C, Rosenberg S, Thompson A, Weiss A, Partridge A.

BMJ Open. 2019 Mar 12;9(3):e026797. doi: 10.1136/bmjopen-2018-026797.

16.

Cancer Outcomes in DCIS Patients Without Locoregional Treatment.

Ryser MD, Weaver DL, Zhao F, Worni M, Grimm LJ, Gulati R, Etzioni R, Hyslop T, Lee SJ, Hwang ES.

J Natl Cancer Inst. 2019 Sep 1;111(9):952-960. doi: 10.1093/jnci/djy220.

PMID:
30759222
17.

Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.

Turner MC, Keenan JE, Rushing CN, Gulack BC, Nussbaum DP, Benrashid E, Hyslop T, Strickler JH, Mantyh CR, Migaly J.

J Gastrointest Surg. 2019 Aug;23(8):1614-1622. doi: 10.1007/s11605-018-04079-8. Epub 2019 Jan 11.

PMID:
30635829
18.

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study.

Crosby EJ, Gwin W, Blackwell K, Marcom PK, Chang S, Maecker HT, Broadwater G, Hyslop T, Kim S, Rogatko A, Lubkov V, Snyder JC, Osada T, Hobeika AC, Morse MA, Lyerly HK, Hartman ZC.

Clin Cancer Res. 2019 May 1;25(9):2725-2736. doi: 10.1158/1078-0432.CCR-18-3102. Epub 2019 Jan 11.

PMID:
30635338
19.

Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual.

Plichta JK, Ren Y, Thomas SM, Greenup RA, Fayanju OM, Rosenberger LH, Hyslop T, Hwang ES.

Ann Surg. 2018 Oct 11. doi: 10.1097/SLA.0000000000003071. [Epub ahead of print]

PMID:
30312199
20.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
21.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
22.

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).

Fayanju OM, Ren Y, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, Tamirisa N, Force J, Boughey JC, Hyslop T, Hwang ES.

Ann Surg. 2018 Oct;268(4):591-601. doi: 10.1097/SLA.0000000000002953.

23.

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.

Tanioka M, Fan C, Parker JS, Hoadley KA, Hu Z, Li Y, Hyslop TM, Pitcher BN, Soloway MG, Spears PA, Henry LN, Tolaney S, Dang CT, Krop IE, Harris LN, Berry DA, Mardis ER, Winer EP, Hudis CA, Carey LA, Perou CM.

Clin Cancer Res. 2018 Nov 1;24(21):5292-5304. doi: 10.1158/1078-0432.CCR-17-3431. Epub 2018 Jul 23.

PMID:
30037817
24.

The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.

Park TS, Thomas SM, Rosenberger LH, Fayanju OM, Plichta JK, Blitzblau RC, Ong CT, Hyslop T, Hwang ES, Greenup RA.

Ann Surg Oncol. 2018 Oct;25(10):3019-3029. doi: 10.1245/s10434-018-6587-2. Epub 2018 Jul 5.

PMID:
29978365
25.

Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival.

Tamirisa N, Thomas SM, Fayanju OM, Greenup RA, Rosenberger LH, Hyslop T, Hwang ES, Plichta JK.

Ann Surg Oncol. 2018 Oct;25(10):2890-2898. doi: 10.1245/s10434-018-6595-2. Epub 2018 Jul 2.

26.

Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.

Ong CT, Campbell BM, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, Force J, Hall A, Hyslop T, Hwang ES, Fayanju OM.

Ann Surg Oncol. 2018 Aug;25(8):2249-2260. doi: 10.1245/s10434-018-6533-3. Epub 2018 May 31.

27.

Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Freedman JA, Wang Y, Li X, Liu H, Moorman PG, George DJ, Lee NH, Hyslop T, Wei Q, Patierno SR.

Carcinogenesis. 2018 Jul 3;39(7):879-888. doi: 10.1093/carcin/bgy062.

28.

Tips for Analyzing Large Data Sets From the JAMA Surgery Statistical Editors.

Kaji AH, Rademaker AW, Hyslop T.

JAMA Surg. 2018 Jun 1;153(6):508-509. doi: 10.1001/jamasurg.2018.0647. No abstract available.

PMID:
29617520
29.

Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.

Force J, Howie LJ, Abbott SE, Bentley R, Marcom PK, Kimmick G, Westbrook K, Sammons SL, Parks M, Topping DL, Emerson R, Broadwater G, Hyslop T, Blackwell KL, Nair SK.

Clin Breast Cancer. 2018 Oct;18(5):410-417. doi: 10.1016/j.clbc.2018.02.010. Epub 2018 Feb 24.

PMID:
29615305
30.

Reply to: "Surgeon Volume Threshold for Total Thyroidectomy".

Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.

Ann Surg. 2018 Apr;267(4):e78-e79. doi: 10.1097/SLA.0000000000002161. No abstract available.

PMID:
29517563
31.

Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ.

Grimm LJ, Ryser MD, Hyslop T.

JAMA Surg. 2018 Mar 1;153(3):290-291. doi: 10.1001/jamasurg.2017.5566. No abstract available.

PMID:
29344621
32.

Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).

Magbanua MJM, Rugo HS, Wolf DM, Hauranieh L, Roy R, Pendyala P, Sosa EV, Scott JH, Lee JS, Pitcher B, Hyslop T, Barry WT, Isakoff SJ, Dickler M, Van't Veer L, Park JW.

Clin Cancer Res. 2018 Mar 15;24(6):1486-1499. doi: 10.1158/1078-0432.CCR-17-2312. Epub 2018 Jan 8.

33.

Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.

Lane WO, Thomas SM, Blitzblau RC, Plichta JK, Rosenberger LH, Fayanju OM, Hyslop T, Hwang ES, Greenup RA.

Ann Surg. 2019 Mar;269(3):537-544. doi: 10.1097/SLA.0000000000002621.

34.

GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.

Li P, Wuthrick E, Rappaport JA, Kraft C, Lin JE, Marszalowicz G, Snook AE, Zhan T, Hyslop TM, Waldman SA.

Cancer Res. 2017 Sep 15;77(18):5095-5106. doi: 10.1158/0008-5472.CAN-17-0859.

35.

Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.

Ong CT, Thomas SM, Blitzblau RC, Fayanju OM, Park TS, Plichta JK, Rosenberger LH, Hyslop T, Shelley Hwang E, Greenup RA.

Ann Surg Oncol. 2017 Nov;24(12):3559-3566. doi: 10.1245/s10434-017-6075-0. Epub 2017 Sep 6.

36.

Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.

Xu Y, Wang Y, Liu H, Shi Q, Zhu D, Amos CI, Fang S, Lee JE, Hyslop T, Li X, Han J, Wei Q.

Mol Carcinog. 2018 Jan;57(1):22-31. doi: 10.1002/mc.22716. Epub 2017 Aug 28.

37.

Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.

Adam MA, Thomas S, Roman SA, Hyslop T, Sosa JA.

JAMA Surg. 2017 Sep 1;152(9):869-876. doi: 10.1001/jamasurg.2017.1665.

38.

Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival.

Liu S, Wang Y, Xue W, Liu H, Xu Y, Shi Q, Wu W, Zhu D, Amos CI, Fang S, Lee JE, Hyslop T, Li Y, Han J, Wei Q.

Int J Cancer. 2017 Aug 15;141(4):721-730. doi: 10.1002/ijc.30785. Epub 2017 Jun 1.

39.

Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.

Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q.

Int J Cancer. 2017 Aug 15;141(4):731-743. doi: 10.1002/ijc.30787. Epub 2017 Jun 1.

40.

Modeling qRT-PCR dynamics with application to cancer biomarker quantification.

Chervoneva I, Freydin B, Hyslop T, Waldman SA.

Stat Methods Med Res. 2018 Sep;27(9):2581-2595. doi: 10.1177/0962280216683204. Epub 2017 May 14.

41.

Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.

Anand S, Thomas S, Hyslop T, Adcock J, Corbet K, Gasparetto C, Lopez R, Long GD, Morris AK, Rizzieri DA, Sullivan KM, Sung AD, Sarantopoulos S, Chao NJ, Horwitz ME.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1151-1157. doi: 10.1016/j.bbmt.2017.04.001. Epub 2017 Apr 6.

42.

A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.

Cheng Q, Li X, Acharya CR, Hyslop T, Sosa JA.

Oncotarget. 2017 Mar 7;8(10):16690-16703. doi: 10.18632/oncotarget.15128.

43.

Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?

Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.

Ann Surg. 2017 Feb;265(2):402-407. doi: 10.1097/SLA.0000000000001688.

PMID:
28059969
44.

Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.

Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA.

J Clin Oncol. 2016 Dec 20;34(36):4415-4420. Epub 2016 Oct 28.

45.
46.

The Effect of Hospital Volume on Breast Cancer Mortality.

Greenup RA, Obeng-Gyasi S, Thomas S, Houck K, Lane WO, Blitzblau RC, Hyslop T, Hwang ES.

Ann Surg. 2018 Feb;267(2):375-381. doi: 10.1097/SLA.0000000000002095.

47.

Reply to J. Heil et al.

Hwang ES, Hyslop T.

J Clin Oncol. 2016 Dec;34(34):4192. Epub 2016 Sep 30. No abstract available.

PMID:
27621401
48.

How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.

Robinson TJ, Thomas S, Dinan MA, Roman S, Sosa JA, Hyslop T.

J Clin Oncol. 2016 Oct 1;34(28):3434-9. doi: 10.1200/JCO.2016.67.6437. Epub 2016 Aug 15.

49.

Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.

Sung AD, Sung JAM, Thomas S, Hyslop T, Gasparetto C, Long G, Rizzieri D, Sullivan KM, Corbet K, Broadwater G, Chao NJ, Horwitz ME.

Clin Infect Dis. 2016 Oct 15;63(8):999-1006. doi: 10.1093/cid/ciw451. Epub 2016 Aug 1.

50.

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.

Mod Pathol. 2016 Oct;29(10):1143-54. doi: 10.1038/modpathol.2016.112. Epub 2016 Jun 17.

Supplemental Content

Loading ...
Support Center